Compare Toba Pulp Lestari Tbk (INRU) vs Organon Pharma Indonesia Tbk. (SCPI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Toba Pulp Lestari Tbk vs Organon Pharma Indonesia Tbk. — how do they compare? Toba Pulp Lestari Tbk trades at Rp590 (market cap 826.39B, 34.5K 24h volume), while Organon Pharma Indonesia Tbk. trades at Rp29,000 (market cap 104.4B). The key difference: Toba Pulp Lestari Tbk is far larger — about 7.9× Organon Pharma Indonesia Tbk.'s market cap. Which is the better fit depends on your goals.
| INRU | SCPI | |
|---|---|---|
Market Cap | 826.39B | 104.4B |
Volume | 34.5K | — |
Lot | 345 | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Toba Pulp Lestari Tbk
PT Toba Pulp Lestari Tbk (the Company) was established within the framework of the Foreign Capital Investment Law No. 6 year 1968 as amended by Law No. 12 year 1970 based on Notarial Deed No. 329 dated April 26, 1983 of Misahardi Wilamarta, S.H., public notary in Jakarta.
Read more on INRU →About Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Read more on SCPI →
